,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2019_Mouse,Pathways in cancer,59/535,1.220482398428948e-09,3.270892827789581e-07,0,0,2.6022408963585435,53.40844328518779,GSK3B;CDKN1A;SPI1;HSP90AB1;ITGA2B;GLI3;CCND3;GNGT2;PIM1;AKT1;SKP1A;APPL1;HSP90AA1;APAF1;DAPK1;IFNGR2;F2R;AXIN1;PRKCA;RUNX1;EML4;BCR;CKS2;HDAC2;ROCK1;ROCK2;MGST3;LAMA4;LRP5;HIF1A;HSP90B1;RASGRP3;GNG2;TPR;CTNNA1;E2F3;HES1;STAT5B;EGLN3;SMAD4;BAD;TXNRD1;STAT3;FN1;VEGFB;LAMB1;IGF1;GADD45G;BMP4;APC;CDK4;TRP53;GNAQ;CDK2;MDM2;GRB2;CALM1;CALM2;FGF10
1,KEGG_2019_Mouse,p53 signaling pathway,16/71,1.4850069141223138e-07,1.9899092649239003e-05,0,0,5.956426332288402,93.65096266717254,CDKN1A;RRM2;APAF1;SIVA1;IGF1;PPM1D;GADD45G;CCND3;CCNB1;CDK4;SESN1;TRP53;CDK2;CCNG1;CDK1;MDM2
2,KEGG_2019_Mouse,Cell cycle,21/123,2.895174848918227e-07,2.586356198366949e-05,0,0,4.227837613918807,63.650307282017614,YWHAE;GSK3B;SMAD4;CDKN1A;HDAC2;CDC6;SMC3;YWHAZ;GADD45G;CCND3;CCNB1;YWHAQ;CDK4;RAD21;TRP53;CDC27;CDK2;MDM2;CDK1;E2F3;SKP1A
3,KEGG_2019_Mouse,Regulation of actin cytoskeleton,28/217,1.3753953034225951e-06,9.21514853293139e-05,0,0,3.051431344007763,41.18446511300441,ROCK1;ROCK2;ITGB3;ITGA2B;IQGAP2;MYL12A;MYL12B;CFL2;CFL1;PIP4K2A;PAK2;ACTN1;F2R;FN1;ARPC5;ENAH;DIAPH1;PIKFYVE;MYL7;ABI2;ARPC2;APC;MYH9;ITGA5;PFN1;EZR;VCL;FGF10
4,KEGG_2019_Mouse,Focal adhesion,26/199,2.567375075397815e-06,0.0001376113040413229,0,0,3.0914025211883085,39.79447017856856,GSK3B;ROCK1;ROCK2;ITGB3;LAMA4;ITGA2B;MYL12A;MYL12B;RAP1B;CCND3;CAPN2;AKT1;FLNB;PAK2;BAD;ACTN1;FN1;VEGFB;PRKCA;LAMB1;IGF1;DIAPH1;MYL7;GRB2;ITGA5;VCL
5,KEGG_2019_Mouse,Protein processing in endoplasmic reticulum,22/163,8.796340223552217e-06,0.000392903196651999,0,0,3.200950754603775,37.26282728188789,EDEM3;XBP1;TRAM1;HSP90AA1;HSP90AB1;UBE2D1;UBE2G1;PDIA6;HSP90B1;SEC61A2;DNAJC3;LMAN1;BAG2;LMAN2;CANX;CAPN2;STUB1;P4HB;SKP1A;UGGT1;SEC24C;TXNDC5
6,KEGG_2019_Mouse,Chronic myeloid leukemia,14/76,1.104832709078286e-05,0.0004229930943328296,0,0,4.61179327089837,52.63546439675049,STAT5B;CDKN1A;HDAC2;SMAD4;BAD;RUNX1;GADD45G;BCR;CDK4;TRP53;MDM2;AKT1;E2F3;GRB2
7,KEGG_2019_Mouse,Spliceosome,19/132,1.4071080157340316e-05,0.0004713811852709006,0,0,3.4433580483138004,38.46709194694217,TCERG1;DDX5;RBM25;DDX46;EIF4A3;DDX42;PRPF8;HNRNPK;DDX39B;SRSF2;SRSF3;DHX16;SNRPD3;SNRPF;SRSF5;TXNL4A;HNRNPA1;SRSF7;RBM22
8,KEGG_2019_Mouse,PI3K-Akt signaling pathway,36/357,1.591973279145104e-05,0.0004740542653454309,0,0,2.3140104574087035,25.565074522145306,YWHAE;GSK3B;CDKN1A;HSP90AB1;ITGB3;LAMA4;ITGA2B;PPP2R2A;BRCA1;HSP90B1;CCND3;GNGT2;GNG2;YWHAQ;MYB;AKT1;MAGI1;HSP90AA1;SYK;ANGPT1;BAD;F2R;FN1;VEGFB;PRKCA;LAMB1;IGF1;YWHAZ;CDK4;TRP53;CDK2;MDM2;GRB2;SGK3;ITGA5;FGF10
9,KEGG_2019_Mouse,Rap1 signaling pathway,25/209,1.891573311895954e-05,0.0005069416475881156,0,0,2.790131049817855,30.34411638672068,ITGB3;ITGA2B;FYB;RASGRP3;RAP1B;SIPA1L1;AKT1;MAGI1;ANGPT1;F2R;VEGFB;ARAP3;PRKCA;IGF1;MAPK14;AFDN;GNAQ;PRKD1;PFN1;CALM1;RAPGEF5;CALM2;SKAP1;SIPA1;FGF10
10,KEGG_2019_Mouse,Leukocyte transendothelial migration,17/115,2.7678771323511387e-05,0.0006743555195182774,0,0,3.547608039979746,37.23159585042468,ROCK1;ROCK2;ACTN1;NCF4;PRKCA;F11R;MAPK14;MYL12A;MYL12B;RAP1B;AFDN;MYL7;PECAM1;CTNNA1;EZR;VCL;SIPA1
11,KEGG_2019_Mouse,Proteoglycans in cancer,24/203,3.3436262059897894e-05,0.0007467431860043863,0,0,2.7510808841389363,28.352280731319663,CD63;CDKN1A;DDX5;ROCK1;ROCK2;ITGB3;STAT3;FN1;PRKCA;ANK3;IGF1;MAPK14;HIF1A;TFAP4;CTSL;TRP53;MDM2;AKT1;SDC1;TIMP3;GRB2;FLNB;ITGA5;EZR
12,KEGG_2019_Mouse,Prostate cancer,15/97,4.7432740582287474e-05,0.0009722515688094302,0,0,3.73611803932894,37.19753034613915,GSK3B;CDKN1A;HSP90AA1;HSP90AB1;BAD;IGF1;HSP90B1;ZEB1;TRP53;CDK2;MDM2;AKT1;GRB2;E2F3;ERG
13,KEGG_2019_Mouse,Non-small cell lung cancer,12/66,5.317199237435144e-05,0.0009722515688094302,0,0,4.530758226037196,44.59162622451562,EML4;STAT5B;CDKN1A;BAD;CDK4;TRP53;STAT3;AKT1;PRKCA;E2F3;GRB2;GADD45G
14,KEGG_2019_Mouse,Transcriptional misregulation in cancer,22/183,5.4417065418438256e-05,0.0009722515688094302,0,0,2.8003529998248475,27.49619774834657,SS18;MEF2C;DDX5;CDKN1A;HDAC2;SPI1;H3F3B;DOT1L;HMGA2;IGF1;PBX1;RUNX1;GADD45G;FUT8;MEIS1;MYCN;ZEB1;TRP53;ID2;MDM2;ERG;TCF3
15,KEGG_2019_Mouse,Fluid shear stress and atherosclerosis,18/143,0.00014049579128030566,0.0023533045039451,0,0,2.943913606911447,26.11349408995525,MEF2C;HSP90AA1;HSP90AB1;MGST3;ITGB3;ITGA2B;MAPK14;TXN2;HSP90B1;BMP4;CTSL;TRP53;PECAM1;AKT1;SDC1;CALM1;CALM2;BMPR1A
16,KEGG_2019_Mouse,Glioma,12/75,0.00019112331857457212,0.0030130029045873,0,0,3.8816676885346415,33.237135498120665,CDKN1A;CDK4;TRP53;MDM2;AKT1;PRKCA;E2F3;GRB2;IGF1;CALM1;CALM2;GADD45G
17,KEGG_2019_Mouse,Endometrial cancer,10/58,0.000346888988365434,0.005164791604552,0,0,4.23982869379015,33.77661965731407,GSK3B;CDKN1A;APC;BAD;TRP53;AXIN1;CTNNA1;AKT1;GRB2;GADD45G
18,KEGG_2019_Mouse,Small cell lung cancer,13/92,0.0003733730546878091,0.0052665251924385,0,0,3.3542400304558866,26.47479012073474,CDKN1A;APAF1;LAMA4;ITGA2B;FN1;LAMB1;GADD45G;CDK4;TRP53;CDK2;CKS2;AKT1;E2F3
19,KEGG_2019_Mouse,Wnt signaling pathway,18/160,0.0005670933347067108,0.0075990506850699,0,0,2.589146107748,19.35383260664764,GSK3B;SMAD4;ROCK2;CSNK1A1;CHD8;AXIN1;LRP5;PRKCA;CACYBP;CSNK1E;CCND3;ZNRF3;DAAM1;APC;TRP53;RSPO3;SKP1A;LGR5
20,KEGG_2019_Mouse,Signaling pathways regulating pluripotency of stem cells,16/137,0.0007487209854882119,0.0094214198934313,0,0,2.6980621259618123,19.418342072874285,GSK3B;SMAD4;PCGF5;STAT3;AXIN1;LIFR;IGF1;MAPK14;BMP4;MEIS1;APC;ID2;AKT1;GRB2;TCF3;BMPR1A
21,KEGG_2019_Mouse,Fc gamma R-mediated phagocytosis,12/87,0.0007734001405055608,0.0094214198934313,0,0,3.258540772532189,23.3465126831428,MARCKS;SYK;MYO10;ARPC2;CFL2;INPP5D;CFL1;AKT1;PRKCA;ASAP1;ASAP2;ARPC5
22,KEGG_2019_Mouse,Platelet activation,15/125,0.0008160679454895443,0.0095089656257042,0,0,2.7809961835796067,19.775699847345347,FCER1G;SYK;ROCK1;ROCK2;ITGB3;ITGA2B;F2R;MAPK14;MYL12A;MYL12B;RAP1B;GNAQ;P2RX1;AKT1;FERMT3
23,KEGG_2019_Mouse,Tight junction,18/167,0.0009405503495578384,0.0105028122367291,0,0,2.466595155609028,17.18981356310051,MAGI1;ACTR3;ROCK1;ROCK2;ACTN1;NEDD4L;PPP2R2A;F11R;MYL12A;RUNX1;MYL12B;AFDN;MYL6;CDK4;MYH9;EZR;LLGL1;TJP2
24,KEGG_2019_Mouse,Oocyte meiosis,14/116,0.0011363209674498,0.0121813607710624,0,0,2.7973434535104365,18.965875201605368,YWHAE;IGF1;SMC3;YWHAZ;CCNB1;SLK;YWHAQ;CDC27;CDK2;CDK1;FBXO5;CALM1;SKP1A;CALM2
25,KEGG_2019_Mouse,HIF-1 signaling pathway,13/104,0.0012172207223965,0.0125467366770107,0,0,2.910081325763388,19.53009447819033,CDKN1A;EGLN3;TFRC;ANGPT1;IFNGR2;ENO1B;STAT3;PRKCA;IGF1;PDHB;HIF1A;HK1;AKT1
26,KEGG_2019_Mouse,Viral carcinogenesis,22/229,0.0012844556809884,0.0127494119446265,0,0,2.172749850671193,14.464908843044322,YWHAE;STAT5B;GTF2A1;CDKN1A;HDAC2;SYK;BAD;ACTN1;STAT3;YWHAZ;HDAC7;CCND3;HNRNPK;YWHAQ;CDK4;TRP53;CDK2;MDM2;CDK1;TBPL1;GRB2;HIST1H2BC
27,KEGG_2019_Mouse,Hippo signaling pathway,17/159,0.0014064505363149,0.0132118255402554,0,0,2.4426667882158104,16.040226041631865,YWHAE;GSK3B;SMAD4;AXIN1;PPP2R2A;CSNK1E;YWHAZ;SMAD7;BMP4;CCND3;FRMD6;YWHAQ;APC;ID2;CTNNA1;LLGL1;BMPR1A
28,KEGG_2019_Mouse,FoxO signaling pathway,15/132,0.0014296378383112,0.0132118255402554,0,0,2.6136457729568603,17.12025310172609,SMAD4;CDKN1A;PLK2;STAT3;CSNK1E;IGF1;MAPK14;SIRT1;GADD45G;CCNB1;CDK2;MDM2;AKT1;GRB2;SGK3
29,KEGG_2019_Mouse,Breast cancer,16/147,0.001592322236869,0.0138689371986144,0,0,2.49078704922348,16.04704950011521,GSK3B;CDKN1A;CSNK1A1;AXIN1;LRP5;IGF1;BRCA1;GADD45G;APC;CDK4;TRP53;AKT1;GRB2;E2F3;HES1;FGF10
30,KEGG_2019_Mouse,Ras signaling pathway,22/233,0.0016042427356606,0.0138689371986144,0,0,2.1311079355614724,13.713900027448176,ANGPT1;BAD;VEGFB;PRKCA;IGF1;ETS2;RASGRP3;RAP1B;AFDN;GNGT2;GNG2;NF1;AKT1;ABL2;GRB2;CALM1;RGL1;RAPGEF5;CALM2;PAK2;RAB5A;FGF10
31,KEGG_2019_Mouse,RNA degradation,11/83,0.0017597686257984,0.0147380622410622,0,0,3.108610217934977,19.71658705297661,PAN2;BTG3;TTC37;BTG2;PNLDC1;ENO1B;C1D;PABPC1;DCP1A;PFKP;HSPD1
32,KEGG_2019_Mouse,MicroRNAs in cancer,25/281,0.0018454810918374,0.0149875434124983,0,0,1.997755712731229,12.575902739541318,CDKN1A;ROCK1;ITGB3;BRCA1;PIM1;IGF2BP1;TIMP3;E2F3;ABCC1;STAT3;DNMT3A;HMGA2;PRKCA;DICER1;SIRT1;MARCKS;HNRNPK;ZEB1;APC;TRP53;CCNG1;MDM2;GRB2;ITGA5;EZR
33,KEGG_2019_Mouse,Melanoma,10/72,0.0019676747133566,0.015509906564105,0,0,3.280030393037232,20.4375505008306,CDKN1A;BAD;CDK4;TRP53;MDM2;AKT1;E2F3;IGF1;GADD45G;FGF10
34,KEGG_2019_Mouse,Colorectal cancer,11/88,0.0028202367827257,0.0215949559362997,0,0,2.9059868320318483,17.060858151263886,GSK3B;CDKN1A;SMAD4;APC;BAD;TRP53;AXIN1;AKT1;GRB2;APPL1;GADD45G
35,KEGG_2019_Mouse,Cellular senescence,18/185,0.0029652683331811,0.0220747753692378,0,0,2.1986394381862624,12.797813509335658,CDKN1A;HUS1;MAPK14;SIRT1;ZFP36L1;GADD45G;CCND3;CCNB1;CDK4;TRP53;CDK2;CAPN2;MDM2;CDK1;AKT1;E2F3;CALM1;CALM2
36,KEGG_2019_Mouse,Hepatocellular carcinoma,17/171,0.003057653987937,0.0221473315883006,0,0,2.2509001246865323,13.032953305798271,GSK3B;SMAD4;CDKN1A;BAD;CSNK1A1;MGST3;TXNRD1;AXIN1;LRP5;PRKCA;GADD45G;APC;CDK4;TRP53;AKT1;GRB2;E2F3
37,KEGG_2019_Mouse,Hepatitis C,16/160,0.0037658374011266,0.0265590637763665,0,0,2.264367816091954,12.639214367324104,YWHAE;GSK3B;CDKN1A;APAF1;BAD;STAT3;PPP2R2A;YWHAZ;YWHAQ;CDK4;TRP53;CDK2;AKT1;GRB2;E2F3;EIF3E
38,KEGG_2019_Mouse,Hepatitis B,16/163,0.004515789279655,0.0310315776140397,0,0,2.2178043631245603,11.976532330049006,STAT5B;SMAD4;CDKN1A;APAF1;BAD;STAT3;PRKCA;MAPK14;YWHAZ;YWHAQ;TRP53;CDK2;AKT1;TAB2;GRB2;E2F3
39,KEGG_2019_Mouse,Gastric cancer,15/150,0.0049360492152833,0.0330715297423984,0,0,2.263006817366344,12.019259227542388,GSK3B;SMAD4;CDKN1A;CSNK1A1;AXIN1;LRP5;GADD45G;APC;TRP53;CDK2;CTNNA1;AKT1;GRB2;E2F3;FGF10
40,KEGG_2019_Mouse,RNA transport,16/167,0.0057011123432952,0.035995572185685,0,0,2.158597853391185,11.153677963210582,EIF4A2;EIF4A1;PRMT5;EIF4A3;PNN;FXR2;XPO1;DDX39B;TPR;EIF3E;PABPC1;EIF1A;KPNB1;EIF4G1;PAIP1;NUP37
41,KEGG_2019_Mouse,Ubiquitin mediated proteolysis,14/138,0.0057151529541718,0.035995572185685,0,0,2.298369753728754,11.87023907677844,SMURF2;CUL3;UBE2E1;UBE2D1;NEDD4L;UBE2G1;BRCA1;CDC27;UBE2N;MDM2;UBE2O;BIRC6;STUB1;SKP1A
42,KEGG_2019_Mouse,Sphingolipid signaling pathway,13/124,0.0057754089700912,0.035995572185685,0,0,2.3832264057827968,12.2834973415748,CERS5;ABCC1;FCER1G;ROCK1;ROCK2;PPP2R2A;PRKCA;MAPK14;SPTLC1;TRP53;GNAQ;AKT1;DEGS1
43,KEGG_2019_Mouse,Amino sugar and nucleotide sugar metabolism,7/49,0.0077606419335636,0.046280517851122,0,0,3.382070437566702,16.432432574627672,GMDS;PMM1;UXS1;GFPT2;UAP1;NPL;HK1
44,KEGG_2019_Mouse,Bacterial invasion of epithelial cells,9/74,0.0079014817590418,0.046280517851122,0,0,2.8123241464417936,13.613631480416794,SEPT9;ARPC2;ELMO1;CTNNA1;FN1;ITGA5;ARPC5;VCL;CD2AP
45,KEGG_2019_Mouse,AGE-RAGE signaling pathway in diabetic complications,11/101,0.0080718940219434,0.046280517851122,0,0,2.4845301893533405,11.973863115918354,STAT5B;DIAPH1;SMAD4;CDK4;STAT3;PIM1;FN1;VEGFB;AKT1;PRKCA;MAPK14
46,KEGG_2019_Mouse,Thyroid hormone signaling pathway,12/115,0.0081163594738908,0.046280517851122,0,0,2.3692237176549025,11.405143426352346,BMP4;GSK3B;HDAC2;MED13;BAD;TRP53;ITGB3;MDM2;AKT1;PRKCA;HIF1A;PFKP
47,KEGG_2019_Mouse,Pancreatic cancer,9/75,0.0086135541131391,0.0480923437983601,0,0,2.7695673310646574,13.167681482067737,CDKN1A;SMAD4;BAD;CDK4;TRP53;STAT3;AKT1;E2F3;GADD45G
48,KEGG_2019_Mouse,RNA polymerase,5/28,0.009211759510906,0.0497891064676376,0,0,4.406399036903274,20.65400141698407,POLR2D;POLR1C;POLR2E;POLR3G;POLR2G
49,KEGG_2019_Mouse,Basal cell carcinoma,8/63,0.0092890124006786,0.0497891064676376,0,0,2.952758352758353,13.815729087069732,BMP4;GSK3B;CDKN1A;APC;TRP53;AXIN1;GLI3;GADD45G
50,KEGG_2019_Mouse,Salmonella infection,9/78,0.0110431326017999,0.0580305791623994,0,0,2.6487328528249243,11.93504860236771,DYNC1H1;ROCK1;ARPC2;ROCK2;IFNGR2;FLNB;ARPC5;PFN1;MAPK14
51,KEGG_2019_Mouse,Bladder cancer,6/41,0.0119098119965334,0.0613813387513647,0,0,3.4762717027109358,15.40124870915396,CDKN1A;DAPK1;CDK4;TRP53;MDM2;E2F3
52,KEGG_2019_Mouse,MAPK signaling pathway,23/294,0.0125386256116378,0.063402861583376,0,0,1.731052001073757,7.580175186730238,MEF2C;DUSP3;ANGPT1;CACNA2D3;VEGFB;PRKCA;IGF1;MAPK14;GADD45G;RASGRP3;RAP1B;TAOK1;TRP53;NF1;AKT1;GRB2;FLNB;TAB2;PTPN7;PAK2;MAP3K4;MAP4K4;FGF10
53,KEGG_2019_Mouse,Renal cell carcinoma,8/68,0.0144456738611312,0.0716933443478365,0,0,2.705982905982906,11.466224527525622,RAP1B;CDKN1A;EGLN3;BAD;AKT1;GRB2;HIF1A;PAK2
54,KEGG_2019_Mouse,Acute myeloid leukemia,8/69,0.0156858863319365,0.0764330461265272,0,0,2.6614824155807764,11.05844328335972,STAT5B;SPI1;BAD;STAT3;PIM1;AKT1;GRB2;RUNX1
55,KEGG_2019_Mouse,ECM-receptor interaction,9/83,0.0161846059598591,0.0774548999507544,0,0,2.469114033819916,10.181872548558928,ITGB3;LAMA4;ITGA2B;FN1;SDC1;LAMB1;ITGA5;CD47;HMMR
56,KEGG_2019_Mouse,Hedgehog signaling pathway,6/44,0.0166035443486544,0.0780657874638491,0,0,3.201324206037482,13.11947187310822,GSK3B;SMURF2;CSNK1A1;CUL3;CSNK1E;GLI3
57,KEGG_2019_Mouse,ErbB signaling pathway,9/84,0.0173936524156449,0.0803706697826352,0,0,2.4360641711229944,9.87007926011691,GSK3B;STAT5B;CDKN1A;BAD;AKT1;ABL2;PRKCA;GRB2;PAK2
58,KEGG_2019_Mouse,Necroptosis,15/176,0.0197818798236297,0.0887390346116471,0,0,1.8949448080818887,7.433847487479905,STAT5B;HSP90AA1;HSP90AB1;PARP1;H2AFY;IFNGR2;STAT3;H2AFV;GLUD1;H2AFY2;FTH1;CHMP2B;CAPN2;GLUL;PPIA
59,KEGG_2019_Mouse,Adherens junction,8/72,0.0198669480473836,0.0887390346116471,0,0,2.536324786324786,9.939090436904989,AFDN;SMAD4;FER;PTPRB;ACTN1;CTNNA1;ACP1;VCL
60,KEGG_2019_Mouse,Progesterone-mediated oocyte maturation,9/90,0.0260642273518735,0.1128902795959169,0,0,2.2549019607843137,8.22405927446791,HSP90AA1;CCNB1;HSP90AB1;CDC27;CDK2;CDK1;AKT1;IGF1;MAPK14
61,KEGG_2019_Mouse,Dopaminergic synapse,12/135,0.0261164079662195,0.1128902795959169,0,0,1.981890505600335,7.224370433796971,GSK3B;GNGT2;GNG2;KIF5B;GNAQ;AKT1;PPP2R2A;PRKCA;CALM1;MAPK14;CALM2;SLC18A2
62,KEGG_2019_Mouse,TGF-beta signaling pathway,9/91,0.0277611267449907,0.1180949518675798,0,0,2.227285770183905,7.982856257029339,BMP4;SMAD4;ROCK1;SMURF2;ID2;SKP1A;LTBP1;SMAD7;BMPR1A
63,KEGG_2019_Mouse,"Alanine, aspartate and glutamate metabolism",5/37,0.0288811473152785,0.1209398043827289,0,0,3.165601703940362,11.220684925158512,GLUD1;GOT1;GFPT2;GLUL;ADSS
64,KEGG_2019_Mouse,Arginine and proline metabolism,6/50,0.0295105634248298,0.1216743230439138,0,0,2.763907734056988,9.737266287623516,PYCRL;GOT1;P4HA1;AMD1;ODC1;PYCR2
65,KEGG_2019_Mouse,Endocytosis,20/269,0.0305565045859587,0.1227398411422244,0,0,1.634851092682418,5.702651124245604,ARFGEF1;TFRC;SMURF2;NEDD4L;ARAP3;ASAP1;ARPC5;ASAP2;IGF2R;EPN2;DAB2;RABEP1;UBB;ARPC2;KIF5B;CHMP2B;MDM2;RAB5A;SNX6;SH3GL1
66,KEGG_2019_Mouse,Central carbon metabolism in cancer,7/64,0.0306849602855561,0.1227398411422244,0,0,2.490085940571814,8.675416182596965,TRP53;AKT1;PDHB;SLC16A3;HIF1A;PFKP;HK1
67,KEGG_2019_Mouse,Human cytomegalovirus infection,19/255,0.0337319817755541,0.1329436928801253,0,0,1.638021071919377,5.551759360656574,GSK3B;CDKN1A;ROCK1;ROCK2;ITGB3;STAT3;PRKCA;MAPK14;GNGT2;GNG2;CDK4;TRP53;GNAQ;MDM2;AKT1;GRB2;E2F3;CALM1;CALM2
68,KEGG_2019_Mouse,Apoptosis,12/141,0.0349645943748535,0.1353920117245975,0,0,1.8891106896895895,6.334980282127169,APAF1;PARP1;CTSL;BAD;TRP53;CAPN2;AKT1;BIRC6;SEPT4;GADD45G;LMNB1;CTSB
69,KEGG_2019_Mouse,Human papillomavirus infection,25/360,0.0353635851519471,0.1353920117245975,0,0,1.5202280220226398,5.080712503755918,GSK3B;CDKN1A;HDAC2;ITGB3;LAMA4;ITGA2B;PPP2R2A;CCND3;AKT1;HES1;MAGI1;CSNK1A1;BAD;FN1;AXIN1;LAMB1;APC;CDK4;TRP53;CDK2;MDM2;TBPL1;GRB2;ITGA5;LLGL1
70,KEGG_2019_Mouse,Ferroptosis,5/40,0.0388775700305532,0.1467491375801166,0,0,2.8938080024342003,9.39717211385956,TFRC;GPX4;FTH1;TRP53;SLC3A2
71,KEGG_2019_Mouse,Fc epsilon RI signaling pathway,7/68,0.0408277104575931,0.151969811147708,0,0,2.3263117378448834,7.440462086558085,FCER1G;SYK;INPP5D;AKT1;PRKCA;GRB2;MAPK14
72,KEGG_2019_Mouse,Human T-cell leukemia virus 1 infection,18/245,0.0426433612866891,0.1565537099292148,0,0,1.6123633457341031,5.086818794087793,STAT5B;CDKN1A;SMAD4;SPI1;NFYB;ETS2;CCND3;XPO1;CDK4;TRP53;CDC27;CANX;CDK2;AKT1;TBPL1;TSPO;E2F3;TCF3
73,KEGG_2019_Mouse,Nitrogen metabolism,3/17,0.0434646037820884,0.1574123488324282,0,0,4.336268407469258,13.597706802634402,GLUD1;GLUL;CAR4
74,KEGG_2019_Mouse,Axon guidance,14/180,0.0462433347748551,0.1652428495954825,0,0,1.7130457313123462,5.265624959096503,GSK3B;SEMA6A;ROCK1;ROCK2;PRKCA;MYL12A;MYL12B;ENAH;ABLIM1;CFL2;CFL1;PLXNC1;SRGAP1;PAK2
75,KEGG_2019_Mouse,Th17 cell differentiation,9/102,0.0517499853810991,0.1824867905544022,0,0,1.9627048473348283,5.812218962094677,STAT5B;SMAD4;HSP90AA1;HSP90AB1;IFNGR2;STAT3;MAPK14;HIF1A;RUNX1
76,KEGG_2019_Mouse,Pyrimidine metabolism,6/58,0.0550044773163587,0.1914441548153786,0,0,2.3377070690503525,6.78014693673201,NT5C;DTYMK;UCK2;RRM2;TK1;NME1
77,KEGG_2019_Mouse,Arginine biosynthesis,3/19,0.0577974380727491,0.1985860692755995,0,0,3.793836344314559,10.815509731120798,GLUD1;GOT1;GLUL
78,KEGG_2019_Mouse,Lysine degradation,6/59,0.0589007614988377,0.1993075032826141,0,0,2.2934786981534376,6.4949052144765735,PRDM6;EHMT2;NSD1;DOT1L;KMT5B;ACAT2
79,KEGG_2019_Mouse,Ribosome,13/170,0.0595063994722953,0.1993075032826141,0,0,1.6808650379360597,4.742848835156922,RPL41;MRPL12;MRPS6;RPS26;RPS28;RPS29;RPL37A;RPL36;RPL38;RPL37;RPL15;RPS2;RPS12
80,KEGG_2019_Mouse,Neurotrophin signaling pathway,10/121,0.0602384618130289,0.1993075032826141,0,0,1.827362694600382,5.133873578697613,RAP1B;YWHAE;GSK3B;BAD;TRP53;AKT1;GRB2;CALM1;MAPK14;CALM2
81,KEGG_2019_Mouse,Amoebiasis,9/106,0.0630698253850818,0.2061306488195358,0,0,1.8813716301890957,5.199194632192513,SERPINB6A;ACTN1;GNAQ;LAMA4;FN1;PRKCA;LAMB1;RAB5A;VCL
82,KEGG_2019_Mouse,Epstein-Barr virus infection,16/229,0.076564686522185,0.2472209155174169,0,0,1.5252549781447304,3.919324659757376,CDKN1A;HDAC2;SYK;APAF1;STAT3;MAPK14;GADD45G;CCND3;CDK4;TRP53;CDK2;MDM2;AKT1;TAB2;E2F3;HES1
83,KEGG_2019_Mouse,Measles,11/144,0.0789724239199101,0.2495158126735491,0,0,1.6774492501349838,4.25846752909534,STAT5B;GSK3B;CCND3;APAF1;CDK4;BAD;TRP53;CDK2;STAT3;AKT1;TAB2
84,KEGG_2019_Mouse,Tuberculosis,13/178,0.0791374779001928,0.2495158126735491,0,0,1.59869153402988,4.055190925951432,FCER1G;APAF1;SYK;NFYA;BAD;NFYB;IFNGR2;MAPK14;HSPD1;AKT1;CALM1;CALM2;RAB5A
85,KEGG_2019_Mouse,Cholesterol metabolism,5/49,0.0801566274765364,0.2497904205082765,0,0,2.300803562784393,5.806705254167024,STARD3;SOAT1;VAPA;NPC2;TSPO
86,KEGG_2019_Mouse,Fructose and mannose metabolism,4/35,0.0812170721206496,0.250185923314185,0,0,2.611530542210021,6.556586418871007,GMDS;PMM1;PFKP;HK1
87,KEGG_2019_Mouse,Phagosome,13/180,0.0846228131014458,0.2577149308089487,0,0,1.5793783003273796,3.900355877401654,COLEC12;DYNC1H1;TFRC;ITGB3;NCF4;SEC61A2;TUBB6;PIKFYVE;TUBB5;CTSL;CANX;ITGA5;RAB5A
88,KEGG_2019_Mouse,Kaposi sarcoma-associated herpesvirus infection,15/216,0.0877109687888832,0.2641184228698956,0,0,1.514628150956734,3.6861631262006025,GSK3B;CDKN1A;SYK;STAT3;MAPK14;HIF1A;GNGT2;GNG2;UBB;CDK4;TRP53;AKT1;E2F3;CALM1;CALM2
89,KEGG_2019_Mouse,Alcoholism,14/199,0.0891516545064538,0.2654738156414404,0,0,1.5355652426620168,3.7121005642789737,HDAC2;H3F3B;H2AFY;H2AFV;HDAC7;GNGT2;GNG2;H2AFY2;GRB2;CALM1;SLC29A1;CALM2;SLC18A2;HIST1H2BC
90,KEGG_2019_Mouse,Phosphatidylinositol signaling system,8/98,0.0916990679810532,0.2700587936145305,0,0,1.801139601139601,4.303360298516772,IPPK;PIKFYVE;INPP5D;PIP4K2A;PRKCA;CALM1;CALM2;DGKH
91,KEGG_2019_Mouse,Thyroid cancer,4/37,0.0953060564264741,0.2776306861119029,0,0,2.452998065764023,5.766169140992965,CDKN1A;TRP53;TPR;GADD45G
92,KEGG_2019_Mouse,Amyotrophic lateral sclerosis (ALS),5/52,0.0976398903745855,0.2813708668859023,0,0,2.1536038791833776,5.01029299961235,APAF1;BAD;TRP53;MAPK14;RAB5A
93,KEGG_2019_Mouse,Human immunodeficiency virus 1 infection,16/238,0.0990206516174723,0.2823141982285382,0,0,1.462721342031687,3.38243610304946,BAD;PRKCA;MAPK14;CCNB1;GNGT2;GNG2;CFL2;GNAQ;CFL1;CDK1;AKT1;TAB2;CALM1;SKP1A;CALM2;PAK2
94,KEGG_2019_Mouse,Longevity regulating pathway,8/102,0.1090392946177815,0.3076055890270046,0,0,1.724131660301873,3.820756725550561,HDAC2;EHMT2;SESN1;TRP53;AKT1;IGF1;SIRT1;APPL1
95,KEGG_2019_Mouse,African trypanosomiasis,4/39,0.1104570869364904,0.3083593676977024,0,0,2.31258358662614,5.094918084417936,LAMA4;GNAQ;HBA-A2;PRKCA
96,KEGG_2019_Mouse,B cell receptor signaling pathway,6/72,0.1239335628390795,0.3389203555191154,0,0,1.840472959875945,3.8429252833303744,GSK3B;SYK;INPP5D;AKT1;GRB2;RASGRP3
97,KEGG_2019_Mouse,Prolactin signaling pathway,6/72,0.1239335628390795,0.3389203555191154,0,0,1.840472959875945,3.8429252833303744,GSK3B;STAT5B;STAT3;AKT1;GRB2;MAPK14
98,KEGG_2019_Mouse,Cushing syndrome,11/159,0.1320799218332754,0.3484267559777069,0,0,1.5062425769821268,3.049159255448866,RAP1B;MRAP;GSK3B;CDKN1A;APC;CDK4;GNAQ;CDK2;AXIN1;E2F3;PBX1
99,KEGG_2019_Mouse,Lysosome,9/124,0.1321375574058029,0.3484267559777069,0,0,1.5853894443152756,3.208688399898494,LAPTM4B;CD63;LAPTM4A;GGA3;CTSL;NPC2;LITAF;IGF2R;CTSB
100,KEGG_2019_Mouse,Antigen processing and presentation,7/90,0.1326101832452466,0.3484267559777069,0,0,1.707718815496779,3.4501750352428875,HSP90AA1;HSP90AB1;NFYA;CTSL;NFYB;CANX;CTSB
101,KEGG_2019_Mouse,GnRH signaling pathway,7/90,0.1326101832452466,0.3484267559777069,0,0,1.707718815496779,3.4501750352428875,GNAQ;PRKCA;GRB2;MAPK14;CALM1;CALM2;MAP3K4
102,KEGG_2019_Mouse,Toxoplasmosis,8/108,0.1381488911862675,0.3594553673584437,0,0,1.62017094017094,3.2070040341101564,BAD;IFNGR2;LAMA4;STAT3;AKT1;TAB2;LAMB1;MAPK14
103,KEGG_2019_Mouse,Pertussis,6/76,0.1489932934764604,0.3839442562662635,0,0,1.7349375571123973,3.303067780576366,CFL2;CFL1;ITGA5;MAPK14;CALM1;CALM2
104,KEGG_2019_Mouse,Osteoclast differentiation,9/128,0.151401098538215,0.3864332800784917,0,0,1.5317754909450412,2.8917205157497845,SPI1;SYK;ITGB3;IFNGR2;NCF4;AKT1;TAB2;GRB2;MAPK14
105,KEGG_2019_Mouse,Hematopoietic cell lineage,7/94,0.1556577587014742,0.3935498050188215,0,0,1.628859529680197,3.029834340311224,TFRC;ITGB3;ITGA2B;ITGA5;CD34;IL9R;CD55
106,KEGG_2019_Mouse,Salivary secretion,6/78,0.16231353431321,0.4065423102424327,0,0,1.6865671641791045,3.066559285763125,SLC12A2;GNAQ;PRKCA;ATP2B1;CALM1;CALM2
107,KEGG_2019_Mouse,Glutamatergic synapse,8/114,0.1707371534229406,0.4213646454863965,0,0,1.5279793581680374,2.700902182731715,SLC38A1;GNGT2;GNG2;GNAQ;SLC1A3;PRKCA;GLUL;SLC38A2
108,KEGG_2019_Mouse,Influenza A,11/168,0.1713759192463329,0.4213646454863965,0,0,1.4192216055324582,2.503358996863633,IVNS1ABP;DNAJC3;GSK3B;XPO1;DDX39B;IFNGR2;AKT1;TRIM25;PRKCA;KPNA2;MAPK14
109,KEGG_2019_Mouse,Glyoxylate and dicarboxylate metabolism,3/31,0.1785413617926011,0.4349916814583373,0,0,2.166540154850463,3.732807831103621,GLDC;GLUL;ACAT2
110,KEGG_2019_Mouse,Estrogen signaling pathway,9/134,0.1827093406803971,0.4399869528633356,0,0,1.4577882352941176,2.4780340015814404,HSP90AA1;HSP90AB1;KRT18;GNAQ;AKT1;GRB2;CALM1;CALM2;HSP90B1
111,KEGG_2019_Mouse,Glutathione metabolism,5/64,0.1838751444801999,0.4399869528633356,0,0,1.7144997382718723,2.903502416645895,RRM2;GPX4;MGST3;IDH1;ODC1
112,KEGG_2019_Mouse,Sphingolipid metabolism,4/48,0.1898441534790544,0.4445124203781168,0,0,1.8386847195357836,3.055069883779258,CERS5;SPTLC1;DEGS1;B4GALT6
113,KEGG_2019_Mouse,Citrate cycle (TCA cycle),3/32,0.1905769165675102,0.4445124203781168,0,0,2.0917219392429183,3.4674462128447923,ACLY;IDH1;PDHB
114,KEGG_2019_Mouse,Oxytocin signaling pathway,10/154,0.1924008983726177,0.4445124203781168,0,0,1.4061384725196289,2.317560971296368,MEF2C;MYL6;CDKN1A;ROCK1;ROCK2;GNAQ;CACNA2D3;PRKCA;CALM1;CALM2
115,KEGG_2019_Mouse,mTOR signaling pathway,10/154,0.1924008983726177,0.4445124203781168,0,0,1.4061384725196289,2.317560971296368,PRR5;GSK3B;LRP5;AKT1;PRKCA;SLC38A9;GRB2;SLC3A2;IGF1;FNIP1
116,KEGG_2019_Mouse,Huntington disease,12/192,0.1974679996853325,0.4523198625270865,0,0,1.3502145922746782,2.1902893988405125,HDAC2;UQCRB;APAF1;TRP53;GNAQ;POLR2D;POLR2E;TBPL1;TFAM;POLR2G;IFT57;ATP5G1
117,KEGG_2019_Mouse,Apelin signaling pathway,9/138,0.2050544751791559,0.4657169436272356,0,0,1.4122870289764955,2.23773999037774,MEF2C;SMAD4;GNGT2;GNG2;GNAQ;AKT1;TFAM;CALM1;CALM2
118,KEGG_2019_Mouse,Long-term potentiation,5/67,0.2088043904406709,0.4702485431773094,0,0,1.631282421244289,2.5551712857744264,RAP1B;GNAQ;PRKCA;CALM1;CALM2
119,KEGG_2019_Mouse,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.2147675959458372,0.479062272228439,0,0,5.050901378579003,7.769290361616318,HK1
120,KEGG_2019_Mouse,Amphetamine addiction,5/68,0.2173486724742426,0.479062272228439,0,0,1.6053045286272123,2.450099936655733,PRKCA;CALM1;SIRT1;CALM2;SLC18A2
121,KEGG_2019_Mouse,Fanconi anemia pathway,4/51,0.219522863087421,0.479062272228439,0,0,1.7210502489814397,2.6096265856750267,FANCM;REV1;HES1;BRCA1
122,KEGG_2019_Mouse,Gap junction,6/86,0.2201644571993043,0.479062272228439,0,0,1.51727078891258,2.296207993553781,TUBB6;TUBB5;GNAQ;CDK1;PRKCA;GRB2
123,KEGG_2019_Mouse,Chemokine signaling pathway,12/197,0.2216556781952479,0.479062272228439,0,0,1.313374318524533,1.9787692812167548,RAP1B;STAT5B;GSK3B;GNGT2;GNG2;ROCK1;ROCK2;BAD;STAT3;ELMO1;AKT1;GRB2
124,KEGG_2019_Mouse,JAK-STAT signaling pathway,10/164,0.2474213642602942,0.530471404974071,0,0,1.314135543257599,1.8354037906301048,STAT5B;CCND3;CDKN1A;IFNGR2;STAT3;PIM1;AKT1;LIFR;GRB2;IL9R
125,KEGG_2019_Mouse,GABAergic synapse,6/90,0.2513610208358467,0.532882832715498,0,0,1.4447151995126408,1.994956716434232,SLC38A1;GNGT2;GNG2;PRKCA;GLUL;SLC38A2
126,KEGG_2019_Mouse,Arrhythmogenic right ventricular cardiomyopathy (ARVC),5/72,0.2525228349062248,0.532882832715498,0,0,1.5091475529699745,2.0769697513230865,ITGB3;ITGA2B;CACNA2D3;CTNNA1;ITGA5
127,KEGG_2019_Mouse,IL-17 signaling pathway,6/91,0.2593485208142566,0.5404442560140514,0,0,1.42764329612442,1.9267223824739008,GSK3B;HSP90AA1;HSP90AB1;TAB2;MAPK14;HSP90B1
128,KEGG_2019_Mouse,Thyroid hormone synthesis,5/73,0.2615324081591126,0.5404442560140514,0,0,1.4868759005199523,1.9941936032847312,TTR;GNAQ;CANX;PRKCA;HSP90B1
129,KEGG_2019_Mouse,Adrenergic signaling in cardiomyocytes,9/148,0.265254295930422,0.5404442560140514,0,0,1.3099911514638556,1.7384451180562734,GNAQ;CACNA2D3;AKT1;PPP2R2A;PRKCA;ATP2B1;CALM1;MAPK14;CALM2
130,KEGG_2019_Mouse,Aldosterone-regulated sodium reabsorption,3/38,0.2661889619173686,0.5404442560140514,0,0,1.732594504326704,2.293173445101393,NEDD4L;PRKCA;IGF1
131,KEGG_2019_Mouse,Pyruvate metabolism,3/38,0.2661889619173686,0.5404442560140514,0,0,1.732594504326704,2.293173445101393,PDHB;ME2;ACAT2
132,KEGG_2019_Mouse,Gastric acid secretion,5/74,0.2706151151632108,0.5452996305544399,0,0,1.4652498032134094,1.9151660477480048,GNAQ;PRKCA;EZR;CALM1;CALM2
133,KEGG_2019_Mouse,C-type lectin receptor signaling pathway,7/112,0.2777320851956303,0.5531484908857744,0,0,1.3483457844183564,1.727363562733233,FCER1G;SYK;MDM2;AKT1;CALM1;MAPK14;CALM2
134,KEGG_2019_Mouse,Proximal tubule bicarbonate reclamation,2/22,0.2786382323491774,0.5531484908857744,0,0,2.020806794055202,2.5822697680479503,GLUD1;CAR4
135,KEGG_2019_Mouse,VEGF signaling pathway,4/58,0.2926426188147616,0.5756256965203049,0,0,1.4973995271867613,1.840009249002452,BAD;AKT1;PRKCA;MAPK14
136,KEGG_2019_Mouse,cAMP signaling pathway,12/211,0.2950167219786846,0.5756256965203049,0,0,1.2200703086246685,1.4893681796539724,RAP1B;AFDN;ROCK1;ROCK2;BAD;F2R;AKT1;ARAP3;ATP2B1;CALM1;CALM2;GLI3
137,KEGG_2019_Mouse,Phenylalanine metabolism,2/23,0.2964042765664257,0.5756256965203049,0,0,1.924476797088262,2.340223361869752,GOT1;MIF
138,KEGG_2019_Mouse,Porphyrin and chlorophyll metabolism,3/41,0.3052743785411823,0.5885865715758047,0,0,1.595559035740254,1.893201487148123,FECH;CPOX;PPOX
139,KEGG_2019_Mouse,Alzheimer disease,10/175,0.3133245520432822,0.5970166532025042,0,0,1.2258127311660505,1.4225749420544027,GSK3B;UQCRB;APAF1;BAD;GNAQ;CAPN2;CALM1;CALM2;ATP5G1;RTN4
140,KEGG_2019_Mouse,Vitamin digestion and absorption,2/24,0.3141020451550488,0.5970166532025042,0,0,1.8369040725728625,2.127203545162972,CUBN;ABCC1
141,KEGG_2019_Mouse,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/8,0.3208211048324321,0.6011437943335564,0,0,2.8857748825935463,3.280755557137615,GOT1
142,KEGG_2019_Mouse,Riboflavin metabolism,1/8,0.3208211048324321,0.6011437943335564,0,0,2.8857748825935463,3.280755557137615,ACP1
143,KEGG_2019_Mouse,Long-term depression,4/61,0.32496030784728,0.6011437943335564,0,0,1.4183650615901455,1.594316415840611,GNAZ;GNAQ;PRKCA;IGF1
144,KEGG_2019_Mouse,Circadian entrainment,6/99,0.3252457096207674,0.6011437943335564,0,0,1.3042850264805008,1.464939490348916,GNGT2;GNG2;GNAQ;PRKCA;CALM1;CALM2
145,KEGG_2019_Mouse,Basal transcription factors,3/43,0.3314726951086333,0.6084567280076284,0,0,1.5156216790648247,1.6735643724152367,GTF2A1;TBPL1;TAF2
146,KEGG_2019_Mouse,Vascular smooth muscle contraction,8/140,0.3414182114371543,0.6194929846210623,0,0,1.2253302253302254,1.316797605840376,MYL6;PRKCH;ROCK1;ROCK2;GNAQ;PRKCA;CALM1;CALM2
147,KEGG_2019_Mouse,T cell receptor signaling pathway,6/101,0.3421080661340195,0.6194929846210623,0,0,1.2766917293233082,1.3694160737249113,GSK3B;CDK4;AKT1;GRB2;MAPK14;PAK2
148,KEGG_2019_Mouse,Mitophagy,4/63,0.3466370495854842,0.6222027755301994,0,0,1.370140641904075,1.4516325147464153,UBB;CITED2;TRP53;HIF1A
149,KEGG_2019_Mouse,Aldosterone synthesis and secretion,6/102,0.3505729624603532,0.6222027755301994,0,0,1.263326226012793,1.3242014034596623,GNAQ;PRKCA;PRKD1;ATP2B1;CALM1;CALM2
150,KEGG_2019_Mouse,Glucagon signaling pathway,6/102,0.3505729624603532,0.6222027755301994,0,0,1.263326226012793,1.3242014034596623,GNAQ;AKT1;PDHB;CALM1;CALM2;SIRT1
151,KEGG_2019_Mouse,Vitamin B6 metabolism,1/9,0.3528911264201131,0.6222027755301994,0,0,2.52492046659597,2.6299462840835908,PNPO
152,KEGG_2019_Mouse,Phototransduction,2/27,0.366470739255312,0.6419226020942721,0,0,1.616220806794055,1.6224215981899048,CALM1;CALM2
153,KEGG_2019_Mouse,Pancreatic secretion,6/105,0.3760511237508942,0.6544266309431146,0,0,1.2248497770885831,1.1979400447894657,RAP1B;SLC12A2;GNAQ;PRKCA;RAB27B;ATP2B1
154,KEGG_2019_Mouse,Hypertrophic cardiomyopathy (HCM),5/86,0.382976247715721,0.6589980492355713,0,0,1.2473868970141602,1.1972198751506464,ITGB3;ITGA2B;CACNA2D3;ITGA5;IGF1
155,KEGG_2019_Mouse,Protein export,2/28,0.3835958794057803,0.6589980492355713,0,0,1.5539768087538788,1.4889672424535998,SEC61A2;SEC11C
156,KEGG_2019_Mouse,Glycolysis / Gluconeogenesis,4/67,0.3899887510302385,0.6614999068107844,0,0,1.2828774062816617,1.208005324570049,ENO1B;PDHB;PFKP;HK1
157,KEGG_2019_Mouse,Leishmaniasis,4/67,0.3899887510302385,0.6614999068107844,0,0,1.2828774062816617,1.208005324570049,IFNGR2;NCF4;TAB2;MAPK14
158,KEGG_2019_Mouse,Inflammatory mediator regulation of TRP channels,7/127,0.3927148572152746,0.6619344763125384,0,0,1.1788687299893277,1.1018549860244855,PRKCH;GNAQ;PRKCA;IGF1;CALM1;MAPK14;CALM2
159,KEGG_2019_Mouse,Malaria,3/49,0.409419886798757,0.6810632908692049,0,0,1.3175160559996304,1.1765603246833891,PECAM1;SDC1;HBA-A2
160,KEGG_2019_Mouse,Synthesis and degradation of ketone bodies,1/11,0.4125641091684563,0.6810632908692049,0,0,2.019724284199364,1.7881905028640364,ACAT2
161,KEGG_2019_Mouse,Circadian rhythm,2/30,0.4172170772684379,0.6810632908692049,0,0,1.442826812253564,1.2612450720871131,CSNK1E;SKP1A
162,KEGG_2019_Mouse,Dilated cardiomyopathy (DCM),5/90,0.420723349759171,0.6810632908692049,0,0,1.1884357576896574,1.0289236580646015,ITGB3;ITGA2B;CACNA2D3;ITGA5;IGF1
163,KEGG_2019_Mouse,Cysteine and methionine metabolism,3/50,0.4221813202862948,0.6810632908692049,0,0,1.2894159676215886,1.1118896778829124,GOT1;AMD1;DNMT3A
164,KEGG_2019_Mouse,N-Glycan biosynthesis,3/50,0.4221813202862948,0.6810632908692049,0,0,1.2894159676215886,1.1118896778829124,FUT8;MAN2A1;MGAT4B
165,KEGG_2019_Mouse,Relaxin signaling pathway,7/131,0.4238556523622411,0.6810632908692049,0,0,1.1405997176989018,0.9790478247295176,GNGT2;GNG2;VEGFB;AKT1;PRKCA;GRB2;MAPK14
166,KEGG_2019_Mouse,cGMP-PKG signaling pathway,9/172,0.4243939163252135,0.6810632908692049,0,0,1.115691742396903,0.9562518136385328,MEF2C;ROCK1;ROCK2;BAD;GNAQ;AKT1;ATP2B1;CALM1;CALM2
167,KEGG_2019_Mouse,Galactose metabolism,2/32,0.4498841629554189,0.7176723551907874,0,0,1.346496815286624,1.0755347239172404,PFKP;HK1
168,KEGG_2019_Mouse,Inositol phosphate metabolism,4/73,0.4540762607955659,0.7200735970012525,0,0,1.1709528214616096,0.9244556832097316,IPPK;PIKFYVE;INPP5D;PIP4K2A
169,KEGG_2019_Mouse,Ribosome biogenesis in eukaryotes,6/115,0.4606683184125367,0.7248750162999118,0,0,1.1118913949257645,0.8618014219915618,RRP7A;NOP58;XPO1;UTP18;GTPBP4;WDR43
170,KEGG_2019_Mouse,Purine metabolism,7/136,0.4625135365197199,0.7248750162999118,0,0,1.0961008661984066,0.8451808577739336,NT5C;ATIC;RRM2;GMPR;PFAS;ADSS;NME1
171,KEGG_2019_Mouse,mRNA surveillance pathway,5/96,0.4764554543483599,0.7423840800311655,0,0,1.1097262694706784,0.8227300217247477,PNN;DDX39B;EIF4A3;PPP2R2A;PABPC1
172,KEGG_2019_Mouse,Endocrine and other factor-regulated calcium reabsorption,3/55,0.4843772066015275,0.7434089129713011,0,0,1.1651271151802505,0.8445905363595595,GNAQ;PRKCA;ATP2B1
173,KEGG_2019_Mouse,Renin secretion,4/76,0.4853039257890028,0.7434089129713011,0,0,1.1219858156028368,0.8111732300126632,GNAQ;CALM1;CALM2;CTSB
174,KEGG_2019_Mouse,Insulin signaling pathway,7/139,0.4854349245148421,0.7434089129713011,0,0,1.071019695352673,0.774036685058172,GSK3B;BAD;AKT1;GRB2;CALM1;CALM2;HK1
175,KEGG_2019_Mouse,Base excision repair,2/35,0.4968634488174755,0.7565875243357013,0,0,1.2238950009650646,0.8560411702748647,PARP1;APEX1
176,KEGG_2019_Mouse,Choline metabolism in cancer,5/99,0.5036657373255322,0.7626125288318794,0,0,1.074139532775927,0.7366904893705886,AKT1;PRKCA;GRB2;HIF1A;DGKH
177,KEGG_2019_Mouse,Nicotinate and nicotinamide metabolism,2/36,0.5119450021027847,0.7639091115756373,0,0,1.1878356438116648,0.7953011933202716,NT5C;NAMPT
178,KEGG_2019_Mouse,Melanogenesis,5/100,0.5126131826497166,0.7639091115756373,0,0,1.0627767501821648,0.7101832912288689,GSK3B;GNAQ;PRKCA;CALM1;CALM2
179,KEGG_2019_Mouse,Systemic lupus erythematosus,7/143,0.5155398788973523,0.7639091115756373,0,0,1.0392993910477746,0.6885780617376044,H3F3B;H2AFY2;H2AFY;ACTN1;H2AFV;SNRPD3;HIST1H2BC
180,KEGG_2019_Mouse,Thiamine metabolism,1/15,0.5159236910268297,0.7639091115756373,0,0,1.4423572186032418,0.9545468292721668,ACP1
181,KEGG_2019_Mouse,Legionellosis,3/58,0.5201171220032434,0.7658867510816992,0,0,1.1014008308376002,0.7199871088421961,CLK1;APAF1;HSPD1
182,KEGG_2019_Mouse,Chagas disease (American trypanosomiasis),5/103,0.539041203737704,0.7894155333426486,0,0,1.030079763534807,0.6365514551333803,GNAQ;IFNGR2;AKT1;PPP2R2A;MAPK14
183,KEGG_2019_Mouse,Cytosolic DNA-sensing pathway,3/61,0.5544667886791133,0.8075929313369693,0,0,1.0442669207372934,0.6158547124303491,POLR1C;POLR2E;POLR3G
184,KEGG_2019_Mouse,Phospholipase D signaling pathway,7/149,0.5594371504101283,0.8077112386157047,0,0,0.9950696709606626,0.577960435372529,FCER1G;SYK;F2R;AKT1;PRKCA;GRB2;DGKH
185,KEGG_2019_Mouse,Selenocompound metabolism,1/17,0.5605757103825413,0.8077112386157047,0,0,1.261930010604454,0.730393693754283,TXNRD1
186,KEGG_2019_Mouse,Tyrosine metabolism,2/40,0.5692143544817858,0.8156939547809753,0,0,1.0625768242261706,0.5987601218503925,GOT1;MIF
187,KEGG_2019_Mouse,"Parathyroid hormone synthesis, secretion and action",5/107,0.5732040701230174,0.8156939547809753,0,0,0.9894756624694606,0.5506565466216795,MEF2C;CDKN1A;GNAQ;LRP5;PRKCA
188,KEGG_2019_Mouse,Autophagy,6/130,0.580799024972206,0.8156939547809753,0,0,0.9766146227388404,0.5306440379469869,DAPK1;CTSL;BAD;AKT1;HIF1A;CTSB
189,KEGG_2019_Mouse,Other glycan degradation,1/18,0.5813341244894265,0.8156939547809753,0,0,1.1876364543696587,0.6442091695596733,FUCA2
190,KEGG_2019_Mouse,Pantothenate and CoA biosynthesis,1/18,0.5813341244894265,0.8156939547809753,0,0,1.1876364543696587,0.6442091695596733,PANK1
191,KEGG_2019_Mouse,One carbon pool by folate,1/19,0.6011128967804872,0.8347059913843035,0,0,1.1215977377165076,0.5708624201139552,ATIC
192,KEGG_2019_Mouse,Steroid biosynthesis,1/19,0.6011128967804872,0.8347059913843035,0,0,1.1215977377165076,0.5708624201139552,SOAT1
193,KEGG_2019_Mouse,Carbohydrate digestion and absorption,2/43,0.6088709244973731,0.8368072193092102,0,0,0.9846719486303144,0.4885439833160487,AKT1;HK1
194,KEGG_2019_Mouse,Vasopressin-regulated water reabsorption,2/43,0.6088709244973731,0.8368072193092102,0,0,0.9846719486303144,0.4885439833160487,DYNC1H1;RAB5A
195,KEGG_2019_Mouse,Mineral absorption,2/44,0.6214568494881683,0.8459525869897366,0,0,0.9611768274188656,0.4572210516866527,FTH1;ATP2B1
196,KEGG_2019_Mouse,Cholinergic synapse,5/113,0.6218382822275302,0.8459525869897366,0,0,0.9342089693527392,0.4438195283403365,GNGT2;GNG2;GNAQ;AKT1;PRKCA
197,KEGG_2019_Mouse,Drug metabolism,5/114,0.6296154721120005,0.8522068006364452,0,0,0.925589393362058,0.4282202375807372,UCK2;RRM2;MGST3;TK1;NME1
198,KEGG_2019_Mouse,Cortisol synthesis and secretion,3/69,0.638468906230628,0.859847572210092,0,0,0.917302676069945,0.4115774771061103,MRAP;GNAQ;PBX1
199,KEGG_2019_Mouse,Mismatch repair,1/22,0.6550224386171055,0.873363251489474,0,0,0.9612179972731404,0.4066776723771086,EXO1
200,KEGG_2019_Mouse,Other types of O-glycan biosynthesis,1/22,0.6550224386171055,0.873363251489474,0,0,0.9612179972731404,0.4066776723771086,GXYLT1
201,KEGG_2019_Mouse,Natural killer cell mediated cytotoxicity,5/118,0.6597351653834039,0.8752921996175854,0,0,0.8926366780702498,0.3712625809405528,FCER1G;SYK;IFNGR2;PRKCA;GRB2
202,KEGG_2019_Mouse,ABC transporters,2/48,0.6686678170712824,0.8819344635659373,0,0,0.8774116126650051,0.3531299904822193,ABCC1;ABCG1
203,KEGG_2019_Mouse,Terpenoid backbone biosynthesis,1/23,0.671323248386012,0.8819344635659373,0,0,0.917478068061313,0.3656191541412225,ACAT2
204,KEGG_2019_Mouse,Parkinson disease,6/144,0.6793375925564467,0.8842694257273309,0,0,0.8768888476870307,0.3390377472170908,UQCRB;UBB;APAF1;UBE2G1;ATP5G1;SLC18A2
205,KEGG_2019_Mouse,Notch signaling pathway,2/49,0.6796996332083215,0.8842694257273309,0,0,0.8586981072412703,0.3315470266850507,HDAC2;HES1
206,KEGG_2019_Mouse,Histidine metabolism,1/24,0.6868545890441612,0.8892610138349526,0,0,0.8775416109548619,0.3296332983091098,CARNMT1
207,KEGG_2019_Mouse,Asthma,1/25,0.701652746112117,0.9040525767213816,0,0,0.8409331919406151,0.2979566406930661,FCER1G
208,KEGG_2019_Mouse,AMPK signaling pathway,5/126,0.7150567381771448,0.9128004717730858,0,0,0.8332673232469922,0.2794723484391671,AKT1;PPP2R2A;IGF1;SIRT1;PFKP
209,KEGG_2019_Mouse,NF-kappa B signaling pathway,4/102,0.715254101016224,0.9128004717730858,0,0,0.8231871471993053,0.2758643475021241,SYK;PARP1;TRIM25;TAB2
210,KEGG_2019_Mouse,Glycosaminoglycan biosynthesis,2/53,0.7208483064368869,0.913186437672601,0,0,0.7911827151242663,0.2589751141979455,FUT8;EXTL3
211,KEGG_2019_Mouse,Butanoate metabolism,1/27,0.7291861853057336,0.913186437672601,0,0,0.7761644506077168,0.2451330545408407,ACAT2
212,KEGG_2019_Mouse,Collecting duct acid secretion,1/27,0.7291861853057336,0.913186437672601,0,0,0.7761644506077168,0.2451330545408407,SLC4A1
213,KEGG_2019_Mouse,Maturity onset diabetes of the young,1/27,0.7291861853057336,0.913186437672601,0,0,0.7761644506077168,0.2451330545408407,HES1
214,KEGG_2019_Mouse,Mucin type O-glycan biosynthesis,1/28,0.7419858095380444,0.9248939393311436,0,0,0.7473783433486508,0.2230365021498341,GALNT1
215,KEGG_2019_Mouse,Serotonergic synapse,5/132,0.7521590991204677,0.9332344377976174,0,0,0.7936487970952513,0.2260370578981727,GNGT2;GNG2;GNAQ;PRKCA;SLC18A2
216,KEGG_2019_Mouse,Insulin resistance,4/110,0.7685258681087587,0.9444884413883228,0,0,0.7607386591730229,0.2002880775659787,GSK3B;GFPT2;STAT3;AKT1
217,KEGG_2019_Mouse,Inflammatory bowel disease (IBD),2/59,0.774139932886123,0.9444884413883228,0,0,0.7076768354006034,0.1811671309753174,IFNGR2;STAT3
218,KEGG_2019_Mouse,Propanoate metabolism,1/31,0.7768712673727964,0.9444884413883228,0,0,0.6725344644750796,0.1698019195020178,ACAT2
219,KEGG_2019_Mouse,Th1 and Th2 cell differentiation,3/87,0.7847381610560267,0.9444884413883228,0,0,0.7200546531045999,0.1745449703327998,STAT5B;IFNGR2;MAPK14
220,KEGG_2019_Mouse,Viral myocarditis,3/87,0.7847381610560267,0.9444884413883228,0,0,0.7200546531045999,0.1745449703327998,ABL2;CD55;EIF4G1
221,KEGG_2019_Mouse,Pentose phosphate pathway,1/32,0.7874192213402169,0.9444884413883228,0,0,0.6508055964150105,0.1555389513567519,PFKP
222,KEGG_2019_Mouse,Glycerolipid metabolism,2/61,0.7898205766403525,0.9444884413883228,0,0,0.6836158192090396,0.1612987953483751,MBOAT2;DGKH
223,KEGG_2019_Mouse,Complement and coagulation cascades,3/88,0.7911998018905506,0.9444884413883228,0,0,0.7115459148590361,0.1666474324376299,PROS1;F2R;CD55
224,KEGG_2019_Mouse,Calcium signaling pathway,7/189,0.7937772341989037,0.9444884413883228,0,0,0.7747311386585666,0.1789260302085418,GNAQ;P2RX1;F2R;PRKCA;ATP2B1;CALM1;CALM2
225,KEGG_2019_Mouse,Starch and sucrose metabolism,1/33,0.7974690412656537,0.9444884413883228,0,0,0.6304347826086957,0.1426751234647975,HK1
226,KEGG_2019_Mouse,Protein digestion and absorption,3/90,0.8036389503088249,0.9444884413883228,0,0,0.6951152479020851,0.1519557921116113,COL18A1;SLC3A2;SLC38A2
227,KEGG_2019_Mouse,Pentose and glucuronate interconversions,1/34,0.8070442279027085,0.9444884413883228,0,0,0.6112985635785212,0.1310482341116466,DCXR
228,KEGG_2019_Mouse,Prion diseases,1/34,0.8070442279027085,0.9444884413883228,0,0,0.6112985635785212,0.1310482341116466,STIP1
229,KEGG_2019_Mouse,Morphine addiction,3/92,0.8154492054837752,0.9457538240753516,0,0,0.6794230378870195,0.1386132691553855,GNGT2;GNG2;PRKCA
230,KEGG_2019_Mouse,DNA replication,1/35,0.8161671746852557,0.9457538240753516,0,0,0.5932880044912981,0.1205181960212719,DNA2
231,KEGG_2019_Mouse,Cell adhesion molecules (CAMs),6/170,0.8187122656174686,0.9457538240753516,0,0,0.7368557907327474,0.1473877970062596,VCAN;PECAM1;SDC1;F11R;CD34;MPZL1
232,KEGG_2019_Mouse,RIG-I-like receptor signaling pathway,2/68,0.837374367286935,0.9555438518376688,0,0,0.6108859293572669,0.1084225001221945,TRIM25;MAPK14
233,KEGG_2019_Mouse,Retrograde endocannabinoid signaling,5/150,0.8416996729479362,0.9555438518376688,0,0,0.6944658661084793,0.1196786995037289,GNGT2;GNG2;GNAQ;PRKCA;MAPK14
234,KEGG_2019_Mouse,Glycerophospholipid metabolism,3/97,0.8423600409832369,0.9555438518376688,0,0,0.6431139349266285,0.1103247511141382,LPGAT1;MBOAT2;DGKH
235,KEGG_2019_Mouse,Toll-like receptor signaling pathway,3/99,0.8521347560746377,0.9555438518376688,0,0,0.6296493092454836,0.1007505639210303,AKT1;TAB2;MAPK14
236,KEGG_2019_Mouse,Adipocytokine signaling pathway,2/71,0.8545998418064211,0.9555438518376688,0,0,0.5842333610264931,0.0917958796116553,STAT3;AKT1
237,KEGG_2019_Mouse,NOD-like receptor signaling pathway,7/205,0.8557098552518785,0.9555438518376688,0,0,0.7115229132304906,0.1108722855557018,HSP90AA1;HSP90AB1;NAMPT;TAB2;MAPK14;CTSB;TXN2
238,KEGG_2019_Mouse,Fat digestion and absorption,1/40,0.8557109120934348,0.9555438518376688,0,0,0.5170894852761236,0.0805742690839941,ACAT2
239,KEGG_2019_Mouse,"Glycine, serine and threonine metabolism",1/40,0.8557109120934348,0.9555438518376688,0,0,0.5170894852761236,0.0805742690839941,GLDC
240,KEGG_2019_Mouse,Homologous recombination,1/41,0.8625349242480992,0.9591674676285916,0,0,0.5041357370095441,0.0745514108033015,BRCA1
241,KEGG_2019_Mouse,Synaptic vesicle cycle,2/77,0.884147094914015,0.970912579292845,0,0,0.5373248407643312,0.0661617926808459,SLC1A3;SLC18A2
242,KEGG_2019_Mouse,Glycosphingolipid biosynthesis,1/45,0.8867554544543164,0.970912579292845,0,0,0.4582088113371252,0.0550702999091556,ST3GAL6
243,KEGG_2019_Mouse,Cardiac muscle contraction,2/78,0.8884952043312819,0.970912579292845,0,0,0.5302268409878199,0.0626866138212541,UQCRB;CACNA2D3
244,KEGG_2019_Mouse,Proteasome,1/46,0.8921125647472031,0.970912579292845,0,0,0.4480028278543655,0.051145329230317,PSME4
245,KEGG_2019_Mouse,TNF signaling pathway,3/110,0.8969523292656613,0.970912579292845,0,0,0.5645912580571474,0.0614007463424419,AKT1;TAB2;MAPK14
246,KEGG_2019_Mouse,Cocaine addiction,1/48,0.9020792247907404,0.970912579292845,0,0,0.4288937523972834,0.0441987580209294,SLC18A2
247,KEGG_2019_Mouse,Tryptophan metabolism,1/48,0.9020792247907404,0.970912579292845,0,0,0.4288937523972834,0.0441987580209294,ACAT2
248,KEGG_2019_Mouse,Type II diabetes mellitus,1/48,0.9020792247907404,0.970912579292845,0,0,0.4288937523972834,0.0441987580209294,HK1
249,KEGG_2019_Mouse,Fatty acid degradation,1/50,0.9111260284805484,0.9732932109206608,0,0,0.4113446014673101,0.0382855082006116,ACAT2
250,KEGG_2019_Mouse,Rheumatoid arthritis,2/84,0.9115544624667382,0.9732932109206608,0,0,0.4912744031898918,0.0454939435257903,ANGPT1;CTSL
251,KEGG_2019_Mouse,Insulin secretion,2/86,0.9181912693346576,0.976489127705112,0,0,0.4795268425841674,0.0409274029460884,GNAQ;PRKCA
252,KEGG_2019_Mouse,Non-alcoholic fatty liver disease (NAFLD),4/151,0.9300959379647444,0.9806098205320116,0,0,0.5473729917498914,0.039666773656463,GSK3B;XBP1;UQCRB;AKT1
253,KEGG_2019_Mouse,Regulation of lipolysis in adipocytes,1/56,0.9335571035513,0.9806098205320116,0,0,0.3663549599922877,0.025188056205434,AKT1
254,KEGG_2019_Mouse,"Valine, leucine and isoleucine degradation",1/56,0.9335571035513,0.9806098205320116,0,0,0.3663549599922877,0.025188056205434,ACAT2
255,KEGG_2019_Mouse,Ovarian steroidogenesis,1/57,0.9367019181201306,0.9806098205320116,0,0,0.3597939706105135,0.0235269892726819,IGF1
256,KEGG_2019_Mouse,Metabolism of xenobiotics by cytochrome P450,1/66,0.9590907220859964,0.9999943981146704,0,0,0.3098295130108491,0.0129414572612175,MGST3
257,KEGG_2019_Mouse,Type I diabetes mellitus,1/69,0.9646317339259716,0.9999943981146704,0,0,0.2961137795521177,0.0106627235863649,HSPD1
258,KEGG_2019_Mouse,Herpes simplex virus 1 infection,13/433,0.972233329276375,0.9999943981146704,0,0,0.6195795611477674,0.0174470213047615,APAF1;SYK;BAD;IFNGR2;ITGB3;TRP53;SRSF2;AKT1;SRSF3;TAB2;SRSF5;ITGA5;SRSF7
259,KEGG_2019_Mouse,Peroxisome,1/84,0.9829218915962012,0.9999943981146704,0,0,0.2424075943221454,0.0041756213963773,IDH1
260,KEGG_2019_Mouse,Arachidonic acid metabolism,1/89,0.9866031977275284,0.9999943981146704,0,0,0.2285741829750313,0.0030828597847323,PTGES3
261,KEGG_2019_Mouse,Steroid hormone biosynthesis,1/89,0.9866031977275284,0.9999943981146704,0,0,0.2285741829750313,0.0030828597847323,DHRS11
262,KEGG_2019_Mouse,Oxidative phosphorylation,2/134,0.9884565784117204,0.9999943981146704,0,0,0.3043813935533681,0.0035340396752594,UQCRB;ATP5G1
263,KEGG_2019_Mouse,Chemical carcinogenesis,1/94,0.9894915017352232,0.9999943981146704,0,0,0.2162282352136284,0.0022842572228559,MGST3
264,KEGG_2019_Mouse,Thermogenesis,4/231,0.9955861267217324,0.9999943981146704,0,0,0.3529665385696879,0.0015613980197895,UQCRB;GRB2;MAPK14;ATP5G1
265,KEGG_2019_Mouse,Cytokine-cytokine receptor interaction,5/292,0.9983144038725964,0.9999943981146704,0,0,0.3482279688155165,0.0005874669709263097,BMP4;IFNGR2;LIFR;IL9R;BMPR1A
266,KEGG_2019_Mouse,Neuroactive ligand-receptor interaction,3/348,0.9999887873998164,0.9999943981146704,0,0,0.17290578940073,1.9387343551187667e-06,P2RX1;F2R;TSPO
267,KEGG_2019_Mouse,Olfactory transduction,2/1133,0.9999943981146704,0.9999943981146704,0,0,0.0336492704162372,1.8849988227836186e-07,CALM1;CALM2
